Champions Oncology Inc expected to post a loss of 12 cents a share - Earnings Preview

Champions Oncology

21/07/2023 23:27

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected
to show a
fall in quarterly revenue when it reports  results on July 21. 
    * The Baltimore Maryland-based  company is expected to
report  a
0.1% decrease in revenue to $12.86 million from $12.88 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Champions Oncology
Inc is
for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $9.5​, above​ its last closing price of $6.97.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jan. 31 2023  -0.06       -0.03      -0.18     Missed  -414.3
 Oct. 31 2023  -0.01       -0.01      0.00      Beat    100
 Jul. 31 2022  0.01        0.01       -0.02     Missed  -300​
 Apr. 30 2022              0.03       -0.03     Missed  -220
 ​​Jan.        0.02        0.03       0.05      Beat    100
 31 2022                                                
 Oct. 31 2021  0.01        0.01       0.02      Beat    300​
 Jul. 31 2021  0.01        0.01       -0.01     Missed  -200
 Apr. 30 2021  0.00        0.00       -0.04     Missed  
 This summary was machine generated July 21 at 22:27 GMT.  All
figures in US dollars  unless otherwise stated